Next-generation Sequencing Services Market To Reach $40.43 Billion By 2033

Next-generation Sequencing Services Market Growth & Trends

The global next-generation sequencing services market size is expected to reach USD 40.43 billion by 2033, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.54% from 2025 to 2033. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.

Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.

With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.

 Request a free sample copy or view report summary: Next-Generation Sequencing Services Market Report

Next-generation Sequencing Services Market Report Highlights

• The human genome segment held the largest market share of 31.28% in 2024. Human genome sequencing services offer access to genomic information related to human genes, providing solutions for personalized medicine, biomarker discovery, cancer-associated gene information, and pharmacogenomics. 

• The sequencing segment held the largest market share of 55.53% in 2024. This high share can be attributed to companies undertaking various scientific endeavors to boost the adoption of sequencing services. 

• The universities & other research entities segment led the next-generation sequencing services market with the largest share of 52.66% in 2024. 

• The North America next-generation sequencing services market held the largest share of 45.56% in 2024

Next-generation Sequencing Services Market Segmentation

Grand View Research has segmented the global next-generation sequencing services market on the basis of service type, workflow, end use, and region:

Next-generation Sequencing Services Type Outlook (Revenue, USD Million, 2021 - 2033)

• Human Genome Sequencing Services

• Single Cell Sequencing Services

• Microbial Genome-based Sequencing Services

• Gene Regulation Services

  • Small RNA Sequencing

  • ChIP Sequencing

  • Other Gene Regulation-based Services

• Animal & Plant Sequencing Services

• Other Sequencing Services

Next-generation Sequencing Services Workflow Outlook (Revenue, USD Million, 2021 - 2033)

• Pre-sequencing

• Sequencing

• Data Analysis

Next-generation Sequencing Services End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Universities & Other Research Entities

• Hospitals & Clinics

• Pharma & Biotech Entities

• Others

Next-generation Sequencing Services Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Switzerland

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

  • Singapore

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Next-generation Sequencing Services Market

• Illumina, Inc.

• Thermo Fisher Scientific Inc.

• BGI Genomics

• Eurofins Genomics

• GENEWIZ

• Macrogen Inc.

• QIAGEN N.V.

• Agilent Technologies Inc.

• Revvity, Inc.

• Twist Bioscience